Clinical Trials Directory

Trials / Completed

CompletedNCT04731090

Standard Antibiotic Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy

Effect of Standard Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Egyptian Biomedical Research Network · Network
Sex
All
Age
20 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Background and aim: Urinary tract infections (UTIs) are commonly seen after flexible ureteroscopy. Prevention of UTIs remains controversial. The present randomized study aimed to compare the rate of post-procedural UTI in patients subjected to the standard antibiotic prophylaxis alone versus enhanced prophylactic measures. Patients and methods: The study included 100 patients subjected to fURS for management of ureteral and/or renal stones. Patients were equally and randomly allocated into one of the two treatment groups using randomly computer-generated allocation tables and concealed envelope technique. Treatment groups included standard antibiotic prophylaxis group and enhanced prophylaxis group. Patients in the standard antibiotic prophylaxis group IV fluoroquinolone 1 hour preoperatively and oral antibiotics were used for 24h postoperatively. In the enhanced prophylaxis group, patients had urine culture 10 days before the procedure. In addition to the antibiotic prophylaxis, hydrophilic-coated ureteral access sheaths were systematically used.

Conditions

Interventions

TypeNameDescription
DRUGIV fluoroquinolone 1 hour preoperatively and oral antibiotics for 24h postoperatively.IV fluoroquinolone 1 hour preoperatively and oral antibiotics for 24h postoperatively.
OTHERUrine culture, antibiotic prophylaxis and hydrophilic-coated ureteral access sheathsPatients had urine culture 10 days before the procedure. In addition to the antibiotic prophylaxis, hydrophilic-coated ureteral access sheaths were systematically used.

Timeline

Start date
2018-08-01
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2021-01-29
Last updated
2021-01-29

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT04731090. Inclusion in this directory is not an endorsement.